Accolade Partners X-B Form D Filed
A Form D filing for Accolade Partners X-B is dated October 28; the filing details are not provided.
Related stories
Coherus Reports 89% Confirmed Response Rate in Esophageal Cancer Trial
Coherus Oncology reported an 89% confirmed response rate for a tagmokitug combination in a first-line esophageal cancer trial.
M impact | EQUITY | Oct 29, 2026, 12:21 PM UTC
Merck Opens South Korea Bioprocessing Center With Major Investment
Merck opened a bioprocessing center in South Korea.
M impact | EQUITY | Oct 29, 2026, 12:21 PM UTC
Borr Drilling Reports Three Dead After Prospector 5 Drilling Rig Accident
Borr Drilling reported three deaths after an accident on the Prospector 5 drilling rig.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Cemtrex Preliminary Q4 Revenue Rises 22% Year Over Year
Cemtrex said preliminary fourth-quarter revenue rose 22% year over year.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Anker Innovations Q3 net profit falls 27.0% year over year
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Ameriprise 3Q-end assets reach $1.8 trillion, up 8%
Ameriprise Financial reported 3Q-end assets under management, administration and advisement of $1.8 trillion, up 8%.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC